Department of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
"Monaldi" Hospital, AORN Ospedali dei Colli, Naples, Italy.
Infez Med. 2021 Mar 1;29(1):70-78.
Clostridioides difficile (CD) is a major nosocomial pathogen and the leading cause of antibiotic-associated diarrhoea. In light of the strong association between antimicrobial use and CD infections (CDI), it may be hypothesised that areas at higher prevalence of antimicrobial resistance, like the region of Campania in southern Italy, could also have a higher rate of CDI. In this multicentre, region-based, prospective study, we analysed such issues, exploiting CDI incidence data collected from local hospitals. In 2016, the Italian National Centre for Disease Control supported a project involving three Italian regions: Friuli Venezia Giulia, Lazio and Campania. In Campania, a network of 49 hospitals willing to participate in the project was created. The project consisted of two phases: a survey on practice patterns concerning CDI and an epidemiological surveillance study. We identified a stringent need to improve awareness about CDI among the regional health-care community, as a widespread lack of surveillance programmes for CDI control was observed (existing in only 40% of participating facilities). Moreover, almost half of the participating hospitals (n=16, 43%) had no standardised procedures or protocols to control and prevent CDI. In the second phase of the study, we collected data of CDI cases during a six-month surveillance programme. In all, 87 CDI cases were observed, for a total of 903,334 patient bed-days and 122,988 admissions. According to the above data, CDI incidence was 0.96 cases/10000 patient bed-days, much lower than expected based on prior studies conducted elsewhere. The results of our study suggest CDI remains a rather neglected clinical issue in Campania. Despite a high burden of antimicrobial resistance and antimicrobial use in our geographic setting, we observed a very low incidence of CDI. Such a low incidence could be explained by underdiagnosis, but could also be related to actual diet, the lower patient age or the specific genetic background. However, further studies are warranted to either confirm or rebut the above hypotheses.
艰难梭菌(CD)是一种主要的医院病原体,也是抗生素相关性腹泻的主要原因。鉴于抗菌药物的使用与 CD 感染(CDI)之间存在很强的关联,因此可以假设,在抗菌药物耐药率较高的地区,如意大利南部的坎帕尼亚地区,CDI 的发生率也可能较高。在这项多中心、基于地区的前瞻性研究中,我们利用从当地医院收集的 CDI 发病率数据来分析这些问题。2016 年,意大利国家疾病控制中心支持了一个涉及意大利三个地区的项目:弗留利-威尼斯朱利亚、拉齐奥和坎帕尼亚。在坎帕尼亚,建立了一个由 49 家愿意参与该项目的医院组成的网络。该项目包括两个阶段:一项关于 CDI 实践模式的调查和一项流行病学监测研究。我们发现,需要提高该地区医疗保健界对 CDI 的认识,因为观察到 CDI 控制的监测方案普遍缺乏(仅在 40%的参与机构中存在)。此外,几乎一半的参与医院(n=16,43%)没有控制和预防 CDI 的标准化程序或方案。在研究的第二阶段,我们收集了为期六个月的监测计划中 CDI 病例的数据。共观察到 87 例 CDI 病例,总计 903334 个患者住院日和 122988 例住院。根据上述数据,CDI 的发病率为 0.96 例/10000 个患者住院日,远低于其他地方进行的先前研究的预期。我们的研究结果表明,CDI 在坎帕尼亚仍然是一个相当被忽视的临床问题。尽管在我们的地理环境中存在很高的抗菌药物耐药率和抗菌药物使用,但我们观察到 CDI 的发病率非常低。这种低发病率可能是由于诊断不足,但也可能与实际饮食、较低的患者年龄或特定的遗传背景有关。然而,需要进一步的研究来证实或反驳上述假设。